Johnson & Johnson: Steady Blue Chip Healthcare Name with Analyst Upgrades

# "Johnson & Johnson Stock Analysis: Performance, Valuation & Expert Forecasts" - Podcast Episode Discover the latest financial insights on healthcare giant Johnson & Johnson (JNJ) in this comprehensive market analysis. We break down JNJ's current trading position at approximately $202 per share, examining recent price movements between the $201-$203.45 range with trading volumes holding steady at 7.78 million shares. Our episode explores JNJ's impressive market capitalization of $486 billion, its investor-friendly P/E ratio of 19x for 2025, and the reliable 2.5% dividend yield that continues to attract income-focused investors. Learn why Wall Street analysts have turned increasingly bullish, with Goldman Sachs, Guggenheim, and JPMorgan all raising their price targets, culminating in a consensus "moderate buy" rating. We also discuss recent corporate developments, including John Morikis joining the board, and examine how JNJ has delivered an exceptional 24% return in 2025, outperforming the broader healthcare sector while maintaining its quarterly dividend of $1.30 per share. Perfect for investors seeking insights into blue-chip healthcare stocks and dividend investment strategies. Subscribe to Quiet Please productions for more expert financial analysis at quietplease.ai. #StockAnalysis #JohnsonAndJohnson #InvestmentStrategy #DividendStocks #HealthcareSector For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.